NCT04711213View on ClinicalTrials.gov

A Clinical Study to Assess the Efficacy and Safety of SED80 for Use in Cataract Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

October 31, 2020

Study Completion Date

November 15, 2020

Conditions
Cataract in Inflammatory Ocular Disorders
Interventions
DRUG

Dexamethasone Dose 1

Dexamethasone ophthalmic suspension dose 1

DRUG

Dexamethasone Dose 2

Dexamethasone ophthalmic suspension dose 2

DRUG

Placebo Dose 1

Placebo suspension dose 1

DRUG

Placebo Dose 2

Placebo suspension dose 2

Trial Locations (1)

Unknown

Centre De. Oftalmologia, San Salvador

All Listed Sponsors
lead

iDrop, Inc.

INDUSTRY

NCT04711213 - A Clinical Study to Assess the Efficacy and Safety of SED80 for Use in Cataract Surgery | Biotech Hunter | Biotech Hunter